Literature DB >> 7507606

High level of hepatitis C endemicity in Gabon, equatorial Africa.

E Delaporte1, V Thiers, M C Dazza, R Romeo, N Mlika-Cabanne, I Aptel, D Schrijvers, C Bréchot, B Larouzé.   

Abstract

To assess the prevalence of hepatitis C virus (HCV) infection, a community-based study was performed in eastern Gabon on 1172 subjects over 5 years of age. The prevalence of antibodies to HCV (anti-HCV) detected using second-generation enzyme-linked immunosorbent assay (ELISA) and confirmed by an immunoblot assay (RIBA 2), was 6.5%. Anti-HCV prevalence increased with age but was related to neither sex nor ethnic group. Among 30 subjects with positive ELISA results, 14 had HCV viraemia as shown by the polymerase chain reaction (11/12 RIBA positive, 2/15 RIBA negative, 1/3 RIBA indeterminate). We conclude that HCV is highly endemic in western equatorial Africa and that a high proportion of the population may be viraemic.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7507606     DOI: 10.1016/0035-9203(93)90269-v

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  8 in total

1.  Clinical guidelines on the management of hepatitis C.

Authors:  J C Booth; J O'Grady; J Neuberger
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

2.  Classification of hepatitis C viruses based on phylogenetic analysis of the envelope 1 and nonstructural 5B regions and identification of five additional subtypes.

Authors:  L Stuyver; W van Arnhem; A Wyseur; F Hernandez; E Delaporte; G Maertens
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

3.  The management of chronic hepatitis C virus infection.

Authors:  J C Booth; J L Brown; H C Thomas
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

Review 4.  Pathophysiology and treatment of hepatitis C.

Authors:  H C Thomas; J Booth; J Brown
Journal:  Drugs       Date:  1996       Impact factor: 9.546

5.  Hepatitis C virus infection may lead to slower emergence of P. falciparum in blood.

Authors:  Odile Ouwe-Missi-Oukem-Boyer; Fousseyni S Touré Ndouo; Benjamin Ollomo; Jérome Mezui-Me-Ndong; Florian Noulin; Isabelle Lachard; Guy-Roger Ndong-Atome; Maria Makuwa; Pierre Roques; Michel Branger; Pierre-Marie Preux; Dominique Mazier; Sylvie Bisser
Journal:  PLoS One       Date:  2011-01-10       Impact factor: 3.240

6.  Phylogeography, risk factors and genetic history of hepatitis C virus in Gabon, central Africa.

Authors:  Richard Njouom; Mélanie Caron; Guillaume Besson; Guy-Roger Ndong-Atome; Maria Makuwa; Régis Pouillot; Dieudonné Nkoghé; Eric Leroy; Mirdad Kazanji
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

7.  Hepatitis C virus prevalence and genetic diversity among pregnant women in Gabon, central Africa.

Authors:  Guy-Roger Ndong-Atome; Maria Makuwa; Richard Njouom; Michel Branger; Francoise Brun-Vézinet; Antoine Mahé; Dominique Rousset; Mirdad Kazanji
Journal:  BMC Infect Dis       Date:  2008-06-17       Impact factor: 3.090

Review 8.  Variability of hepatitis C virus.

Authors:  P Simmonds
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.